PLSE
Pulse Biosciences, Inc. · Healthcare
Chief Commercial Officer Kevin Patrick Danahy sold $1.4M of Pulse Biosciences, Inc.
Sold$1,403,400
$23.39Price
60,000Shares
−58%Stake
What PLSE did after the filing
- The stock from Wed, Feb 11 close, $25.25
- −14.9%
- S&P 500, same days
- −6.8%
Measured over 30 trading days, to the Mar 26 close.
Traded Mon, Feb 9. Filed Wed, Feb 11, 2:46 PM ET, during the session. Returns use the Feb 11 close and the Mar 26 close. Not investment advice.